These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Tumour-associated monoclonal antibodies for the diagnosis and assessment of ovarian cancer. Shepherd JH; Granowska M; Britton KE; Mather S; Epenetos AA; Ward BG; Slevin M Br J Obstet Gynaecol; 1987 Feb; 94(2):160-7. PubMed ID: 3828255 [TBL] [Abstract][Full Text] [Related]
6. Kinetics, quantitative analysis and radioimmunolocalization using indium-111-HMFG1 monoclonal antibody in patients with breast cancer. Kalofonos HP; Sackier JM; Hatzistylianou M; Pervez S; Taylor-Papadimitriou J; Waxman JH; Lavender JP; Wood C; Epenetos AA Br J Cancer; 1989 Jun; 59(6):939-42. PubMed ID: 2736231 [TBL] [Abstract][Full Text] [Related]
7. Generation and characterization of three monoclonal antibodies to human ovarian epithelial adenocarcinomas. Qian HN; Feng J; Cui H; Fu TY; Wei P; Fu ZY Chin Med J (Engl); 1989 Nov; 102(11):839-43. PubMed ID: 2517724 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies for successful tumour imaging. Burchell J; Taylor-Papadimitriou J; Granowska M; Britton K Behring Inst Mitt; 1984 May; (74):87-93. PubMed ID: 6541035 [TBL] [Abstract][Full Text] [Related]
13. The use of radiolabelled monoclonal antibodies to human milk fat globule membrane antigens in antibody-guided tumour imaging, and administration of therapeutic dose of labelled antibody in wide-spread ovarian carcinoma. A preliminary report. Ashorn R; Ashorn P; Punnonen R; Pöyhönen L; Turjanmaa V; Koskinen M; Helle M; Uusitalo A; Pystynen P; Krohn K Ann Chir Gynaecol Suppl; 1985; 197():5-10. PubMed ID: 3863532 [TBL] [Abstract][Full Text] [Related]
14. Antibody-guided diagnosis and therapy of malignant lesions. Kalofonos HP; Stewart S; Epenetos AA Int J Cancer Suppl; 1988; 2():74-80. PubMed ID: 3162448 [TBL] [Abstract][Full Text] [Related]
15. Limitations to the killing of tumours using radiolabelled antibodies. Vaughan AT; Anderson P; Dykes PW; Chapman CE; Bradwell AR Br J Radiol; 1987 Jun; 60(714):567-72. PubMed ID: 3620814 [TBL] [Abstract][Full Text] [Related]
16. Radionuclide imaging of epithelial ovarian tumours with 123I-labelled monoclonal antibody (H317) specific for placental-type alkaline phosphatase. Critchley M; Brownless S; Patten M; McLaughlin PJ; Tromans PM; McDicken IW; Johnson PM Clin Radiol; 1986 Mar; 37(2):107-12. PubMed ID: 3698490 [TBL] [Abstract][Full Text] [Related]
17. Immunoscintigraphy with 131I-labelled monoclonal antibodies HMFG2 and HMFG1 F(ab')2 versus abdominal CT scan in the detection of residual disease in ovarian cancer patients. Pectasides D; Pateniotis K; Tzimis L; Trapalli X; Natsis P; Arapantoni P; Taylor-Papadimitriou J; Epenetos A; Koutsiouba P; Athanassiou A Int J Cancer Suppl; 1988; 3():83-8. PubMed ID: 3209305 [TBL] [Abstract][Full Text] [Related]
18. Immunoscintigraphy with 131I-labelled HMFG2 and HMFG1 F(ab')2 in the pre-operative detection of clinical and subclinical lymph node metastases in breast cancer patients. Athanassiou A; Pectasides D; Pateniotis K; Tzimis L; Natsis P; Lafi A; Arapantoni P; Koutsiouba P; Taylor-Papadimitriou J; Epenetos A Int J Cancer Suppl; 1988; 3():89-95. PubMed ID: 3209306 [TBL] [Abstract][Full Text] [Related]
19. Breast cancer imaging with radiolabelled peptide from complementarity-determining region of antitumour antibody. Sivolapenko GB; Douli V; Pectasides D; Skarlos D; Sirmalis G; Hussain R; Cook J; Courtenay-Luck NS; Merkouri E; Konstantinides K Lancet; 1995 Dec 23-30; 346(8991-8992):1662-6. PubMed ID: 8551823 [TBL] [Abstract][Full Text] [Related]
20. Radionuclide imaging of ovarian tumours with a radiolabelled (123I) monoclonal antibody (NDOG2). Jackson PC; Pitcher EM; Davies JO; Davies ER; Sadowski CS; Staddon GE; Stirrat GM; Sunderland CA Eur J Nucl Med; 1985; 11(1):22-8. PubMed ID: 4043110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]